Daniel Wendling

Research interests

Publications

• Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy

  JAMA · 2022 · 10.1001/jama.2022.15459

• Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial

  Annals of the Rheumatic Diseases · 2020 · 10.1136/annrheumdis-2020-218547

• Microvascular endothelial dysfunction in rheumatoid arthritis

  Nature Reviews Rheumatology · 2018 · 10.1038/s41584-018-0022-8

• Update of French society for rheumatology recommendations for managing rheumatoid arthritis

  Joint Bone Spine · 2018 · 10.1016/j.jbspin.2018.10.002

• Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug

  JAMA · 2016 · 10.1001/jama.2016.13512

• Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

  Arthritis & Rheumatology · 2015 · 10.1002/art.39518

• Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey

  Orphanet Journal of Rare Diseases · 2015 · 10.1186/s13023-015-0228-7

• French guidelines for the management of chikungunya (acute and persistent presentations). November 2014

  Médecine et Maladies Infectieuses · 2015 · 10.1016/j.medmal.2015.05.007

• Physical activity in patients with rheumatoid arthritis

  Joint Bone Spine · 2015 · 10.1016/j.jbspin.2015.10.002

• Hidradenitis Suppurativa Associated with Spondyloarthritis — Results from a Multicenter National Prospective Study

  The Journal of Rheumatology · 2014 · 10.3899/jrheum.130977

• Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial

  Annals of the Rheumatic Diseases · 2014 · 10.1136/annrheumdis-2014-205348

• Cryotherapy in inflammatory rheumatic diseases: a systematic review

  Expert Review of Clinical Immunology · 2013 · 10.1586/1744666x.2014.870036

• Paradoxical effects of anti-TNF-α agents in inflammatory diseases

  Expert Review of Clinical Immunology · 2013 · 10.1586/1744666x.2014.866038

• The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: Study design and baseline characteristics of the 708 recruited patients

  Joint Bone Spine · 2011 · https://doi.org/10.1016/j.jbspin.2011.01.013

• 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

  Annals of the Rheumatic Diseases · 2011 · https://doi.org/10.1136/ard.2011.151027

• New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases

  Seminars in Arthritis and Rheumatism · 2011 · 10.1016/j.semarthrit.2011.05.005

• Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

  Annals of the Rheumatic Diseases · 2010 · 10.1136/ard.2010.137422

• Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis

  Joint Bone Spine · 2007 · 10.1016/j.jbspin.2006.11.005

• Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one‐year randomized controlled trial comparing systematic versus on‐demand treatment

  Arthritis & Rheumatism · 2007 · 10.1002/art.23167

• Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis

  Annals of the Rheumatic Diseases · 2007 · 10.1136/ard.2007.076604

• The Contribution of Adipose Tissue and Adipokines to Inflammation in Joint Diseases

  Current Medicinal Chemistry · 2007 · 10.2174/092986707780362826

• Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion

  Joint Bone Spine · 2006 · 10.1016/j.jbspin.2006.01.007

• The use of TNF-α blocking agents in rheumatoid arthritis: an overview

  Expert Opinion on Pharmacotherapy · 2004 · 10.1517/14656566.5.3.581

• Rheumatic disorders developed after hepatitis B vaccination

  Lara D. Veeken · 1999 · 10.1093/rheumatology/38.10.978

• Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.

  PubMed · 1993

Current projects

No projects listed.